Greenville Eastern North Carolina Alliance’s Post

Thrilled to share some fantastic news! Claradele Pharmaceuticals, an NC startup I had the privilege to coach recently won a prestigious venture challenge. I'm overjoyed to have played a part in helping them refine their pitch and strategy. Coaching startups to successfully secure funding is incredibly rewarding, and seeing their hard work pay off in such a significant way is a true testament to their dedication and potential. Here's to more successes ahead for them and for all the aspiring entrepreneurs in NC! 🚀💼 #StartupCoaching #VentureChallenge #Entrepreneurship #SuccessStories

#fundingalert 💼Company: BIOPHTA 💰Funding: €6.5 Million ⚡Round: Seed 👥Investors: UI Investissement (via the Pertinence Invest 2 Fund, advised by Merieux Equity Partners), Elaia and GO CAPITAL. BIOPHTA, which was founded in 2020 by two #entrepreneurs with experience in developing ocular therapeutics, seeks to utilise the first 7-day continuous #microdosing pharmaceutical form to significantly increase the effectiveness of eye treatments. BIOPHTA overcomes adherence issues encountered with traditional eye drops as well as the high cost and #invasiveness of frequent and painful intraocular injections. Jean GARREC, François Fournier, Ange Tchatchouang, PhD Read more - https://lnkd.in/g9mAJzrw To share your startup story write us on - contact@startuprise.co.uk #BIOPHTA #pharmaceutical #eyetreatments #fundingnews #news #startup #startupnews #startuprise

#fundingalert 💼Company: Rivia 💰Funding: €3 Million ⚡Round: Seed 👥Investors: Speedinvest Rivia is an expert in data infrastructure and AI-driven analytics for biopharmaceutical clinical trials that are more successful. The majority of innovative treatments originate from biopharmas, yet because of antiquated technologies and fragmented data, they frequently experience inefficiencies and failures in clinical trials. In addition to advancing product development to fully realise the promise of integrated trial data and solidify its position as the single data platform for biopharma clinical trials, the money will be utilised to create new teams in the engineering and client services departments. Erik Scalfaro, Andrea Zitna, Marta G. Zanchi, Tiago Kieliger, Kevin Wang, Henk Johan Streefkerk Read more - https://lnkd.in/gyGXJiXf To share your startup story write us on - contact@startuprise.co.uk #Rivia #infrastructure #biopharmaceutical #biopharmas #innovative #development #news #funding #fundingnews #startup #startupnews #startuprise

Roquette Invests in Danish Start-up Biograil™ Roquette, a French multinational supplier of #pharmaceutical and #nutraceutical excipients, announced an investment by its venture capital arm Roquette Ventures in Danish #startup Biograil. Copenhagen-based Biograil is developing a proprietary oral device called BIONDD for delivering biologics that would typically require injection. This advancement, Roquette said, is set to transform patient care by offering a less invasive and more accessible treatment method. Biograil’s BIONDD device is contained in a standard size capsule able to deliver active #therapeutics into the gastrointestinal wall to be effectively distributed in the human body. With this investment, Roquette Ventures joined a consortium that also includes MEGATREND INVEST A/S (Denmark), Verve Investment (Switzerland), HTGF | High-Tech Gründerfonds (Germany), Sanner Ventures (Germany), Evonik Venture Capital (Germany) and Eli Lilly and Company (US). Read more on #CMI online: https://lnkd.in/eiEWPr5G

Biopharma Unicorns Take the Lead in 2024 In 2024, the #biopharmaceutical industry has witnessed an unprecedented surge in the number of #unicorns, i.e., privately held #startups valued at over $1 billion. These unicorns are taking the lead, getting ready to go #public and launch their IPOs. They are reshaping the #healthcare landscape with innovative therapies, cutting-edge technologies, and #strategic collaborations. View insights: https://lnkd.in/gXyRVDSV #aranca #arancainsights #biophamas #technologicaladvancement Shreya Das

What if a simple eyedrop could revolutionize the way we treat retinal diseases? VIAN Therapeutics, a trailblazing biotechnology startup based in San Francisco, is turning this vision into reality. Founded by Juan Pablo Robles, the company is pioneering a non-invasive, groundbreaking solution for diabetic retinopathy and age-related macular degeneration. This game-changing approach aims to halt vision deterioration earlier than traditional methods, offering a glimmer of hope for millions of people worldwide. Want to learn more about how VIAN Therapeutics is redefining ocular care? Check out our latest article: https://lnkd.in/e6ZV44pc #Startups #Biotechnology #Medical #Pharmaceutical #Innovation #RetinalDisease #Aging #VisionCare #FutureOfHealth

Sanofi, a leader in pharmaceutical innovation, is bolstering its AI-driven drug discovery with a significant $140M collaboration with Parisian startup Aqemia. This multi-year partnership aims to develop small molecules across various therapeutic areas. Aqemia's unique approach combines theoretical physics and generative AI, enabling efficient molecule design without the need for supercomputers. This deal marks Sanofi's sixth AI-focused venture since 2021, underscoring its strategy to lead in AI-powered pharmaceuticals. Aqemia, also thriving, plans to double its team by 2024 and establish spinoff companies for each molecule developed, showcasing a dynamic fusion of AI and biotech. #AIinPharma #Sanofi #InnovativeDrugDiscovery

Thoughts on this? >> Alzheimer's biotech Asceneuron raises $100M to see if it can compete with Lilly, Biogen on tau >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #healthcare #productmarketing #pharma #biotech #pharmaceutical

Thoughts on this? >> Alzheimer's biotech Asceneuron raises $100M to see if it can compete with Lilly, Biogen on tau >> Comment below! >>> lqventures.com #strategy #competitiveintelligence #marketing #pharma #biotech #healthcare #pharmaceutical #productmarketing

🔬 What an exciting week in SanFran @ #JPM2024! (I could hardly keep up with it all!) ⁉ What were your highlights?? #Pharma #Biopharma #Healthcare #Innovation #Biotech #DrugDevelopment #Pipeline #MandA #MedDevice #AI #Startups #LifeSciences #RandD #ResearchAndDevelopment #AdvancedTherapeutics #GeneTherapy #CellTherapy #ADC #CRO #CDMO #RWE